Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2026-06-03

EMA Authorised: Nexium Control (esomeprazole) — Haleon Ireland Dungarvan Limited

View source ↗

Summary

Authorised medicinal product Nexium Control (esomeprazole) by Haleon Ireland Dungarvan Limited for gastroesophageal reflux disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nexium Control (esomeprazole)

Snippet

Status: Authorised. Therapeutic area: Gastroesophageal Reflux. MAH: Haleon Ireland Dungarvan Limited. Decision date: 25/02/2025